Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rush

Showing results (401-410 of 565) with videos related to

Pageof 57
Sort By:
Pharmacogenetics and Genomics|December 31, 2010
CYP2C19 variation and citalopram responseDavid A Mrazek, Joanna M Biernacka, Dennis J O'Kane, et al.
Journal of Psychiatric Research|April 8, 2018
A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorderKatherine Sanchez, Michael O Killian, Taryn L Mayes, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive DisorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Psychological Medicine|February 9, 2005
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*DMaurizio Fava, Jonathan E Alpert, Cheryl N Carmin, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 4, 2010
Health-related quality of life in depression: a STAR*D reportElla J Daly, Madhukar H Trivedi, Stephen R Wisniewski, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Family history of depression and therapeutic outcome: findings from STAR*DMustafa M Husain, A John Rush, Stephen R Wisniewski, et al.
Molecular Cell|September 13, 2011
Systematic and quantitative assessment of the ubiquitin-modified proteomeWoong Kim, Eric J Bennett, Edward L Huttlin, et al.
The Australian and New Zealand Journal of Psychiatry|November 6, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effectsScott T Aaronson, Harold A Sackeim, Mei Jiang, et al.
The American Journal of Psychiatry|April 3, 2009
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D reportStephen R Wisniewski, A John Rush, Andrew A Nierenberg, et al.
Neuron|December 13, 2005
Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16Zhifeng Zhou, Eric J Peters, Steven P Hamilton, et al.
Pageof 57

Showing results (401-410 of 565) with videos related to

Sort By:
Pageof 57
Pharmacogenetics and Genomics|December 31, 2010
CYP2C19 variation and citalopram responseDavid A Mrazek, Joanna M Biernacka, Dennis J O'Kane, et al.
Journal of Psychiatric Research|April 8, 2018
A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorderKatherine Sanchez, Michael O Killian, Taryn L Mayes, et al.
Medrxiv : the Preprint Server for Health Sciences|April 18, 2024
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive DisorderSudeepa Bhattacharyya, Siamak MahmoudianDehkordi, Matthew J Sniatynski, et al.
Psychological Medicine|February 9, 2005
Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR*DMaurizio Fava, Jonathan E Alpert, Cheryl N Carmin, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 4, 2010
Health-related quality of life in depression: a STAR*D reportElla J Daly, Madhukar H Trivedi, Stephen R Wisniewski, et al.
The Journal of Clinical Psychiatry|February 5, 2009
Family history of depression and therapeutic outcome: findings from STAR*DMustafa M Husain, A John Rush, Stephen R Wisniewski, et al.
Molecular Cell|September 13, 2011
Systematic and quantitative assessment of the ubiquitin-modified proteomeWoong Kim, Eric J Bennett, Edward L Huttlin, et al.
The Australian and New Zealand Journal of Psychiatry|November 6, 2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effectsScott T Aaronson, Harold A Sackeim, Mei Jiang, et al.
The American Journal of Psychiatry|April 3, 2009
Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D reportStephen R Wisniewski, A John Rush, Andrew A Nierenberg, et al.
Neuron|December 13, 2005
Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron 45, 11-16Zhifeng Zhou, Eric J Peters, Steven P Hamilton, et al.
Pageof 57